Andrew Chepaitis leads ELIA Life Technology, which develops assistive products for people who have a visual impairment. Under his leadership, the company has been awarded roughly $2.5 million in research and development grants. With this funding, the company is developing a suite of products that will enable its consumers to achieve greater levels of education, employment, literacy, and independence.
Chepaitis has worked as a grant reviewer at the National Institutes of Health since 2010. He is the author of four patents. He has also served on the national alumni boards of Lehigh University and the Hopkins School. He was formerly an equity research analyst at Credit Lyonnais USA and a lacrosse coach at Yale University. Chepaitis holds an international business degree from Lehigh University and an MBA from the University of New Haven.